Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122145) titled 'Multicenter Randomized Double-Blind Controlled Study of Leucovorin Calcium in the Treatment of Autism Spectrum Disorder' on April 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Maternity and Children Health Care Hospital of Luohu District
Condition:
Autism Spectrum Disorder
Intervention:
Placebo group:The patients were given placebos in addition to their regular rehabilitation treatment.
Leucovorin Calcium low dose:On the basis of routine rehabilitation for enrolled patients, leucovorin calcium will be administered at 0.5 mg/kg/day, divided into two doses given in the morning ...